FABP1 and cardiovascular disorder: Some of the previously presented biomarkers are not only biomarkers of renal disease and progression but are also the biomarkers of cardiovascular disease like L-FABP which has been related to cardiovascular morbidity/mortality in type 1 and type 2 diabetic patients [35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80].